The effects of dialysate calcium prescription on mortality outcomes in incident patients on hemodialysis
In contrast to the unadjusted analysis that showed a higher risk for dialysate calcium of 1.50 mmol/l, after adjusting for confounders, there were no significant differences in the risk of all-cause and cardiovascular mortality between dialysate calcium concentrations of 1.50 and 1.25 mmol/l. After adjustment, a lower risk of sudden cardiac death was observed in patients with dialysate calcium 1.50 mmol/l. A higher serum-to-dialysate calcium gradient is associated with an increased risk for adverse outcomes.
Authors
- Heleen Bouman (ORCID: https://orcid.org/0000-0002-2164-4011)
- Jeroen P. Kooman
- Karlien J. ter Meulen (ORCID: https://orcid.org/0000-0001-7035-6326)
- Stefano Stuard (ORCID: https://orcid.org/0000-0002-9546-4507)
- Francesco Bellocchio
- Luca Neri (ORCID: https://orcid.org/0000-0001-5438-1329)
- Paola Carioni (ORCID: https://orcid.org/0009-0008-9363-6986)
- Frank M. van der Sande (ORCID: https://orcid.org/0000-0001-5305-3673)
Institutions
- Radboud University Nijmegen (NL)
- Maastricht University Medical Centre (NL)
- Catharina Ziekenhuis (NL)
- Fresenius Medical Care (Germany) (DE)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1093/ckj/sfae288
- Citations
- 2
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.68
Funders
- Universiteit Maastricht
- Maastricht Universitair Medisch Centrum
- European Renal Association-European Dialysis and Transplant Association